I have seen MM's do this type of shake out before huge moves up. The stem cell space is still "young" and by nature will have a lot of consolidation over the years. I doubt competitors enjoy hearing "paradigm shift" in study descriptions.
If we want to just keep it technical, then "what is going on" is a retest of the continuation triangle from Sept. 19th. Price target of $2.10 - $2.25 region. GLTA